{
  "abstract": "Background: Thymic epithelial tumours (TETs) are rare malignancies for which surgical resection is the primary curative treatment. Chemotherapy may be given neoadjuvantly to facilitate resection of locally advanced disease, or adjuvantly to reduce recurrence risk, but the impact of these strategies is not well defined.\n\nMethods: We retrospectively reviewed demographic, disease, treatment and outcome data for all patients with histologically confirmed TETs managed at our centre (April 2011–November 2022). Disease was staged per tumor-node-metastasis (TNM) 8th edition. Survival outcomes were analysed using Kaplan-Meier and log-rank tests.\n\nResults: 206 patients were identified (52% male; median age 63 years); 189 (92%) had thymoma, 16 (8%) thymic carcinoma and 1 thymic atypical carcinoid. Thirty-six patients (17.5%) received neoadjuvant chemotherapy (NACT), given only for stage II–IV disease (30 thymoma, 6 thymic carcinoma), and were compared with 14 stage II–IV patients managed without NACT (10 thymoma, 3 thymic carcinoma and 1 atypical carcinoid). NACT patients had more advanced disease than patients without NACT (Stage III/IV 94.4% vs. 57.1%, P=0.003). All NACT patients proceeded to surgery; R0 resection was achieved in 58.3% of patients (Stage II 100%, Stage III 64.7%, Stage IV 47.1%), and pathologic complete response (pCR) in 11.1% (all thymoma). Recurrence was numerically higher with NACT than without (38.9% vs. 14.3%, P=0.18), 5-year event free survival (EFS) was 46.5% vs. 60.9% (P=0.79), and 5-year overall survival (OS) was 80.9% vs. 66.6% (P=0.47). Thirteen patients (6.3% of total; 11 thymoma, 2 thymic carcinoma) received adjuvant chemotherapy, more often for higher-stage disease (P<0.001) and more aggressive subtypes (P=0.001). Recurrence was 15.4% with adjuvant chemotherapy versus 10.4% without (P=0.63), five-year EFS was 83.3% versus 75.0% (P=0.41), and 5-year OS was 91.7% versus 85.0% (P=0.40).\n\nConclusions: NACT was used predominantly for more advanced disease, achieving pCR in 11% of patients. Adjuvant chemotherapy was similarly reserved for more advanced disease and aggressive histology. Given this confounding by indication, and the small and imbalanced group sizes, no firm conclusions on treatment benefit can be drawn. As the benefit of neoadjuvant and adjuvant chemotherapy in TETs remains unclear, larger studies, such as national registry collaborations, are needed to provide further insight.",
  "abstract_shown": true,
  "affiliations": [
    "Guy’s and St. Thomas’ NHS Foundation Trust, London, UK",
    "King’s College London, London, UK"
  ],
  "article_type": "abstract",
  "arxiv": null,
  "author_total": 24,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Eirini Konstantinidou"
    },
    {
      "affs": [
        0
      ],
      "name": "Eleni Josephides"
    },
    {
      "affs": [
        0
      ],
      "name": "Diluxshan Sritharan"
    },
    {
      "affs": [
        0
      ],
      "name": "Mariam Jallow"
    },
    {
      "affs": [
        0
      ],
      "name": "Shahreen Ahmad"
    },
    {
      "affs": [
        0
      ],
      "name": "Daniel Smith"
    },
    {
      "affs": [
        0
      ],
      "name": "Michael Skwarski"
    },
    {
      "affs": [
        0
      ],
      "name": "Daniel Hughes"
    },
    {
      "affs": [
        0
      ],
      "name": "Sharmistha Ghosh"
    },
    {
      "affs": [
        0
      ],
      "name": "Spyridon Gennatas"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Alexandros Georgiou"
    },
    {
      "affs": [
        1
      ],
      "name": "Mieke Van Hemelrijck"
    },
    {
      "affs": [
        0
      ],
      "name": "Nikolaos Syrigos"
    },
    {
      "affs": [
        0
      ],
      "name": "Marrika Colvin"
    },
    {
      "affs": [
        0
      ],
      "name": "Ellie McDowall"
    },
    {
      "affs": [
        0
      ],
      "name": "Karen Harrison-Phipps"
    },
    {
      "affs": [
        0
      ],
      "name": "Leanne Ashrafian"
    },
    {
      "affs": [
        0
      ],
      "name": "Tom Routledge"
    },
    {
      "affs": [
        0
      ],
      "name": "Carol Tan"
    },
    {
      "affs": [
        0
      ],
      "name": "Akshay Patel"
    },
    {
      "affs": [
        0
      ],
      "name": "George Santis"
    },
    {
      "affs": [
        0
      ],
      "name": "Thomas Young"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Andrea Bille"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Eleni Karapanagiotou"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/cw21hdhsjybk9.bib",
  "cited_by": 0,
  "doi": "10.21037/med-26-ab036",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13744059/",
  "id": "cw21hdhsjybk9",
  "issns": [
    "2522-6711"
  ],
  "landing_url": "https://doi.org/10.21037/med-26-ab036",
  "language": "en",
  "licence": "CC-BY-NC-ND-4.0",
  "licence_label": "CC BY-NC-ND 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Original Research"
    ],
    [
      "openalex",
      "2728|Myasthenia Gravis and Thymoma"
    ]
  ],
  "openalex": "W7225077052",
  "pdf_url": null,
  "pmcid": "PMC13744059",
  "pmid": null,
  "published": "2026-10-30",
  "publisher": "AME Publications",
  "ris": "https://research.draconitic.com/paper/cw21hdhsjybk9.ris",
  "sources": [
    {
      "first_seen": "2026-11-11T12:21:38Z",
      "native_id": "PMC13744059",
      "source": "pmc",
      "url": "https://doi.org/10.21037/med-26-ab036"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2728|Myasthenia Gravis and Thymoma",
      "subfield": "neurology"
    }
  ],
  "title": "AB036. Effect of neoadjuvant and adjuvant chemotherapy in patients with thymic epithelial tumours",
  "title_text": "AB036. Effect of neoadjuvant and adjuvant chemotherapy in patients with thymic epithelial tumours",
  "type": "peer-reviewed",
  "updated_at": "2026-11-11T12:21:38Z",
  "url": "https://research.draconitic.com/paper/cw21hdhsjybk9",
  "venue": "Mediastinum",
  "versions": []
}